vanadates has been researched along with Neuroectodermal Tumors, Primitive, Peripheral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanchetot, C; Buist, A; den Hertog, J | 1 |
| Bahouth, SW; Lopez, S | 1 |
2 other study(ies) available for vanadates and Neuroectodermal Tumors, Primitive, Peripheral
| Article | Year |
|---|---|
Involvement of the membrane distal catalytic domain in pervanadate-induced tyrosine phosphorylation of receptor protein-tyrosine phosphatase alpha.
Topics: Catalytic Domain; Cell Membrane; Enzyme Inhibitors; Humans; Mutagenesis, Site-Directed; Neuroectodermal Tumors, Primitive, Peripheral; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases; Receptor-Like Protein Tyrosine Phosphatases, Class 4; Receptors, Cell Surface; Recombinant Proteins; Transfection; Tumor Cells, Cultured; Tyrosine; Vanadates | 2000 |
Insulin desensitized beta 1-adrenergic receptor-mediated stimulation of adenylyl cyclase in SK-N-MC cells.
Topics: Adenylyl Cyclases; Humans; Insulin; Isoproterenol; Neuroectodermal Tumors, Primitive, Peripheral; Receptor, Insulin; Receptors, Adrenergic, beta; Signal Transduction; Tumor Cells, Cultured; Vanadates | 1992 |